Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Novo Nordisk

Weight-loss jab to be used to prevent other health problems

Some 17,600 people took part in the trial and were either prescribed Wegovy or a dummy drug

The Independent UK

Ozempic knockoffs flood US market thanks to ‘blind spot’ in FDA rules

Pharmacy alliance president counters that ‘it’s an intentional policy’ so patients don’t go without medication

The Guardian - US

Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review

The stock market rally had some wild moves during the week. The Dow Jones and Russell 2000 jumped, but came off highs. The Nasdaq tumbled.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Dow Jones Futures: Netflix Subscribers Jump As Tesla, Nvidia Resilient; President Biden Buzz Heats Up

Stocks retreated Thursday, but Tesla and Nvidia were resilient. Netflix subscribers jumped. President Biden may be close to dropping out, but reports differ.

Investors Business Daily

Dow Jones Futures: Taiwan Semi Lifts Chip Stocks After Nasdaq's Worst Loss Since 2022

Taiwan Semi beat and guided up giving Nvidia and other chip stocks a little lift after the Nasdaq's worst day since 2022.

Investors Business Daily

Eli Lilly, Novo Nordisk — And Their Rivals — Skid On Roche's Weight-Loss Drug Results

Eli Lilly and Novo Nordisk fell Wednesday after Roche released positive early-stage trial data on its oral weight-loss drug.

Investors Business Daily

Novo Nordisk hits out as Dutch agency advises against insurance cover for Wegovy

Novo had last year applied to Dutch authorities for a coverage of the drug under its insurance

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Novo Nordisk Stock Pops After Weight-Loss Drug Cuts Dementia Risk In Yearlong Study

Novo Nordisk stock popped Friday after a study showed its diabetes and weight-loss drug could lower the risk of developing dementia.

Investors Business Daily

Big Pharma’s Monopoly On Ozempic Threatens Access To Diabetes Drug In Communities Of Color

Small pharmacies find difficulty in prescribing the drug due to Big Pharma restrictions on the industry. ‌

Zenger

Pfizer stock leaps on obesity drug challenge to Ozempic, Zepbound

Pfizer is looking to challenge leaders Eli Lilly and Novo Nordisk in the fast-growing market for weight loss drugs.

The Street

Nvidia Chipmaker Taiwan Semi, Arm Stock Among Best Global Stocks To Watch

Arm stock and Nvidia chipmaker Taiwan Semiconductor are among the best global stocks to buy and watch on the stock market today.

Investors Business Daily

Will Novo Nordisk's (NVO) Q2 Earnings Reflect Its Market Potential?

With strong first-quarter results and promising growth in its diabetes and obesity treatments, all eyes are on Novo Nordisk’s (NVO) to see if the pharmaceutical giant can maintain its momentum. Will the upcoming second-quarter earnings report reflect its market potential? Learn more to find out….

StockNews.com

These weight-loss startups tell customers they can stop taking Ozempic or Wegovy and stay thin. Doctors disagree

As nearly $1 billion of venture capital dollars have been injected into weight-loss startups since 2023, companies are making unproven claims to attract customers. It’s a new twist on a story as old as the diet industry.

Fortune

Weight-loss war heats up as Wegovy rival found to lead to faster and greater results

Shares in Novo Nordisk were down 1.1% after the study

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Patients Lost More Weight On Eli Lilly's Mounjaro Than Novo Nordisk's Ozempic

Patients lost more significantly more weight on Eli Lilly's Mounjaro than Novo Nordisk's Ozempic, according to a new study.

International Business Times

Eli Lilly Weight Loss Drug Beats Ozempic In Head-to-head Study

Patients taking Eli Lilly's new drug Mounjaro achieved significantly greater weight loss than those on Novo Nordisk's Ozempic, a head-to-head study published Monday showed.

Investors Business Daily

Copper, Gold Stocks Sparkle On Rate-Cut Hopes, Among 5 Leaders Near Buy Points

Southern Copper and gold stock Agnico eagle surged above early buy points on hopeful signs for U.S. and China policy.

Investors Business Daily

Stock Market: S&P 500, Nasdaq Hit Highs As Tesla Soars, Rate-Cut Hopes Rise: Weekly Review

Tesla drove the S&P 500 and Nasdaq to highs, though small caps fell for the week. Cooling economic data raised rate-cut hopes.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Ozempic maker slams Biden after the president accused the drug company of ‘ripping off’ US consumers

Remarks came after the president and Senator Bernie Sanders blasted the pharmaceutical giant for its ‘unconscionably high prices’

Investors Business Daily

Novo, Lilly Tumble After Study Ties Blindness Disorder To Weight-Loss Drugs

Novo Nordisk stock skidded Wednesday after a new study suggests its diabetes and weight-loss drug can lead to a blindness-causing disease.

The Guardian - UK

Weight-loss jabs may be linked to condition that can cause blindness, study finds

People with diabetes on semaglutide, found in Wegovy and Ozempic, four times more likely to be diagnosed with disease of optic nerve

Evening Standard

Ozempic weight loss drug linked to higher risk of eye condition that causes blindness

US study says patients could have higher risk of developing NAION

Investors Business Daily

Palantir Spearheads This Brigade Of Breakout Stocks

Palantir stock, Google stock, CrowdStrike and Netflix lead the latest IBD Breakout ETF list of breakout stocks to watch.

Investors Business Daily

Dow Jones Jumps 162 Points As Powell Says This On Rate Cuts; Tesla Value Soars $68 Billion As Deliveries Crush Views

The Dow Jones rose after Fed Chair Jerome Powell spoke out on inflation. Tesla surged on deliveries. President Biden hit out at some firms.

Investors Business Daily

Novo, Lilly Fall After Biden Slams Duo For 'Unconscionably High' Drug Prices

Novo Nordisk stock fell Tuesday after Joe Biden and Bernie Sanders slammed the drugmaker and Eli Lilly for high prices of weight-loss drugs.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations